FAQs ABOUT SITADAPA 100/10 TABLET
Q: What is SITADAPA 100/10 TABLET and why is it prescribed?
A: SITADAPA 100/10 TABLET is a combination of Dapagliflozin and Sitagliptin which belongs to the group of medicines called Antidiabetic agents. It is used in adults to manage type II diabetes mellitus which is inadequately controlled on metformin monotherapy.
Q: Does SITADAPA 100/10 TABLET cause weight loss?
A: Yes, SITADAPA 100/10 TABLET may cause weight loss in some individuals. To avoid weight loss, follow a healthy diet and regular physical activity as advised by your physician. However, if the weight loss bothers you, consult your doctor.
Q: Can SITADAPA 100/10 TABLET be taken along with insulin?
A: Taking SITADAPA 100/10 TABLET along with insulin might increase the chance of hypoglycemia (decreased blood sugar levels). Consult your doctor before taking any other medicine with SITADAPA 100/10 TABLET.
Q: How does SITADAPA 100/10 TABLET work?
A: SITADAPA 100/10 TABLET effectively controls blood sugar levels where dapagliflozin inhibits SGLT2, increasing urinary glucose excretion and reducing blood levels of glucose and sitagliptin inhibits DPP-4, increases glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), resulting in increased insulin synthesis and decreased glucagon release.
Q: Is SITADAPA 100/10 TABLET safe to use in patients with kidney problems?
A: SITADAPA 100/10 TABLET can be used with caution in patients who had or have any kidney problems. Your doctor may monitor your kidney function test before and during management with this medicine to prevent the risk of any unusual effects. Consult your doctor before taking SITADAPA 100/10 TABLET.